And when they signed with TPS, they were an unknown commodity. If they can't collect and make cash flow with TPS script, then what good are they?? I know you're on the dark side, and I don't discount your skepticism as you've brought up some valid points in the past. I'm not a rah rah guy like some on this board, but this will be positive for PXYN on a cash flow basis if my reading of the situation is accurate.
1. They have been using NHS for 3 months and have been quite happy. Therefore, you have no grounds to say that TPS was responsible for 99.9% of revenue.
2. What are you going to say if they ALSO sign an agreement with TPS? They are currently negotiating per the 8K.
Market Data 
Markets 
AI
